Submit your #RheumMadness bracket before 11:59pm ET!!!
Submit here:
www.tourneytopia.com/RheumMadness...
Submit your #RheumMadness bracket before 11:59pm ET!!!
Submit here:
www.tourneytopia.com/RheumMadness...
www.themednet.org/v2/programs/...
5/
www.themednet.org/v2/programs/...
5/
@themednet
CME and MOC available through their site!
Explore all the #RheumMadness Q&As 👇
themednet.org/topic/889?sp...
@rheumdr-nina.bsky.social @mbriones.bsky.social
@themednet
CME and MOC available through their site!
Explore all the #RheumMadness Q&As 👇
themednet.org/topic/889?sp...
@rheumdr-nina.bsky.social @mbriones.bsky.social
Next up: the long-term extension of the TULIP trials, showing long-term safety and efficacy of anifrolumab in #lupus
Scouting report by the MUSC fellows
More in 🧵👇
1/
Next up: the long-term extension of the TULIP trials, showing long-term safety and efficacy of anifrolumab in #lupus
Scouting report by the MUSC fellows
More in 🧵👇
1/
⛵ Tocilizumab; 🚁 Rituximab; 🚂 Etane#RheumMadnessv" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">rcept
#RheumMadness
🧭 buff.ly/419uPq<a href="https://buff.ly/4bfAMXS" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">v
📝 Study here: buff.ly/4bfAMXS
⛵ Tocilizumab; 🚁 Rituximab; 🚂 Etane#RheumMadnessv" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">rcept
#RheumMadness
🧭 buff.ly/419uPq<a href="https://buff.ly/4bfAMXS" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">v
📝 Study here: buff.ly/4bfAMXS
Next week @sambhawanabhandari.bsky.social will shoot her shot and show why "Shooting for Remission" should be this year's RheumMadness winner!
@ariellastudies.bsky.social @alhkim.bsky.social @laceyfeigl.bsky.social
Next week @sambhawanabhandari.bsky.social will shoot her shot and show why "Shooting for Remission" should be this year's RheumMadness winner!
@ariellastudies.bsky.social @alhkim.bsky.social @laceyfeigl.bsky.social
@profbeckyg.bsky.social @rheumarhyme.bsky.social
Bracket submissions open until April 1.
Learn more 👇
sites.duke.edu/rheummadness/
.
#RheumMadness
🧠 https://buff.ly/436isy2
🧮 SGCAPS calculator: https://buff.ly/437Pcad
📝 Study here: https://buff.ly/3QtxIh2
.
#RheumMadness
🧠 https://buff.ly/436isy2
🧮 SGCAPS calculator: https://buff.ly/437Pcad
📝 Study here: https://buff.ly/3QtxIh2
https://buff.ly/4basQac
Trial Links:
👑 https://buff.ly/4kcWoYE
👑 https://buff.ly/4hPACIW
https://buff.ly/4basQac
Trial Links:
👑 https://buff.ly/4kcWoYE
👑 https://buff.ly/4hPACIW
Check out the scouting reports for the B-Cell Breakaway Region, including:
-Obinutuzumab for #Lupus nephritis
-CD19 CAR T cells in #Rheumatology
-STRAP Trials on biopsy-guided Rx
Scouting reports 👇
sites.duke.edu/rheummadness/
Check out the scouting reports for the B-Cell Breakaway Region, including:
-Obinutuzumab for #Lupus nephritis
-CD19 CAR T cells in #Rheumatology
-STRAP Trials on biopsy-guided Rx
Scouting reports 👇
sites.duke.edu/rheummadness/
Apparently, a lot of you are crazy about #Rheumatology.
Apparently, a lot of you are crazy about #Rheumatology.
Now I’m in rank 16…not bad, I guess😅??
Definitely better than last year😂👍
#RheumMadness #Rheumsky
Now I’m in rank 16…not bad, I guess😅??
Definitely better than last year😂👍
#RheumMadness #Rheumsky
Q&A about managing sicca in Sjogren's here:
themednet.org/v2/programs/...
14/15
Q&A about managing sicca in Sjogren's here:
themednet.org/v2/programs/...
14/15
First up? The novel CD40L inhibitor in #Sjogren's. Scouting report by #DukeRheum.
More in 🧵👇 (1/15)
First up? The novel CD40L inhibitor in #Sjogren's. Scouting report by #DukeRheum.
More in 🧵👇 (1/15)
#chooserheum #rheumatology #RheumMadness
#chooserheum #rheumatology #RheumMadness
CAR-T discussion starts at min 22:30
Find it here 👇
rheummadness.buzzsprout.com/1465681/epis...
@jeffsparks.bsky.social @nephmadness.bsky.social
bit.ly/NM25Podcrawl
Podcasts:
- @thecurbsiders.bsky.social
- Life as a Nephrology Professional @nkf-professionals.bsky.social
- GN in Ten
- @rheummadness.bsky.social
- @freelyfiltered.bsky.social
- The Poison Lab
- The Nephron Segment
- The Kidney Chronicles
CAR-T discussion starts at min 22:30
Find it here 👇
rheummadness.buzzsprout.com/1465681/epis...
@jeffsparks.bsky.social @nephmadness.bsky.social
@larneson.bsky.social @mbriones.bsky.social
Chicago fellowships bringing the 🔥!
Full scouting report here:
sites.duke.edu/rheummadness...
2/
@larneson.bsky.social @mbriones.bsky.social
Chicago fellowships bringing the 🔥!
Full scouting report here:
sites.duke.edu/rheummadness...
2/
🔗 https://buff.ly/3WLrn4a
hBD-2 (human beta-defensin 2) ⬇️ = 🚫 of the IL17-IL23 axis
Draft a #RheumMadness Rookie? 🏀 https://buff.ly/4jJLklw
🔗 https://buff.ly/3WLrn4a
hBD-2 (human beta-defensin 2) ⬇️ = 🚫 of the IL17-IL23 axis
Draft a #RheumMadness Rookie? 🏀 https://buff.ly/4jJLklw
#existentialcrisis #rheummadness
#existentialcrisis #rheummadness
👇Submit before April 1, 2025 👇
www.tourneytopia.com/RheumMadness...
👇Submit before April 1, 2025 👇
www.tourneytopia.com/RheumMadness...
sites.duke.edu/rheummadness...
3/
sites.duke.edu/rheummadness...
3/
Scouting report by friends from the EMEUNET!
Find the full report here:
sites.duke.edu/rheummadness...
Scouting report by friends from the EMEUNET!
Find the full report here:
sites.duke.edu/rheummadness...